Evidence map›Paper›PMID 25403611›Full record

ReviewHypertension (Dallas, Tex. : 1979)2015

Mitochondria: a pathogenic paradigm in hypertensive renal disease.

Alfonso Eirin, Amir Lerman, Lilach O Lerman

Abstract readReview
In one paragraph

Review in Hypertension (Dallas, Tex. : 1979), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Role of mitochondria in endogenous renal repair.Clinical science (London, England : 1979) · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Mitochondria, a Missing Link in COVID-19 Heart Failure and Arrest?Frontiers in cardiovascular medicine · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alfonso EirinFrom the Divisions of Nephrology and Hypertension (A.E., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, MN.
Amir LermanFrom the Divisions of Nephrology and Hypertension (A.E., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, MN.
Lilach O LermanFrom the Divisions of Nephrology and Hypertension (A.E., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, MN. Lerman.Lilach@Mayo.Edu.

Funding

CT imaging for the assessment of kidney injury distal to renal artery stenosisR01DK073608 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2006 to 2015
$3.1M
Hypoxia and inflammatory injury in human renovascular hypertensionR01DK100081 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O, TEXTOR, STEPHEN C · 2014 to 2018
$2.8M
Noninvasive assessment of renal fibrosis using magnetization transfer MRIU01DK104273 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2014 to 2018
$1.8M
Low-Energy Shockwave Treatment Distal To Peripheral Vascular DiseaseR21HL121561 · NHLBI · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2014 to 2015
$434k
NHLBI NIH HHS HL-121561NHLBI NIH HHS R21 HL121561NIDDK NIH HHS DK100081NIDDK NIH HHS DK73608NIDDK NIH HHS R01 DK073608NIDDK NIH HHS R01 DK100081NIDDK NIH HHS U01 DK104273
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsApoptosisConstriction, PathologicDNA, MitochondrialFibrosisGenes, MitochondrialGenetic Predisposition to DiseaseHumansHypertension, RenalHypertension, RenovascularHypertrophy, Left VentricularIschemiaKidneyMitochondriaOxidative StressReactive Oxygen SpeciesDNA, MitochondrialReactive Oxygen Species

Identifiers

PMID25403611
PMCPMC4289015

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.